Empowering global well-being through innovative solutions, we are dedicated to developing cardiometabolic therapies that provide lasting improvements to the lives of people living with obesity and type 2 diabetes.

EMBARK Laboratories is a Danish biotech company pioneering novel therapeutic solutions for cardiometabolic indications. Founded on ground-breaking scientific discoveries, our goal is delivering safe and well-tolerated strategies that leverage energy expenditure, insulin sensitization, and appetite control, while preserving lean mass.

EMBARK Laboratories is a spin-out from EMBARK Biotech
(Press release)

Empowering global well-being through innovative solutions, we are dedicated to developing cardiometabolic therapies that provide lasting improvements to the lives of people living with obesity and type 2 diabetes.

EMBARK Laboratories is a Danish biotech company pioneering novel therapeutic solutions for cardiometabolic indications. Founded on ground-breaking scientific discoveries, our goal is delivering safe and well-tolerated strategies that leverage energy expenditure, insulin sensitization, and appetite control, while preserving lean mass.

EMBARK Laboratories is a spin-out from EMBARK Biotech
(Press release)

Mads Tang-Christensen
Professor, MD, PhD
CHIEF SCIENTIFIC OFFICER

More than 20 years of experience as a biotech entrepreneur and pharma industry leader. Prior to joining Embark, Mads was CVP at Novo Nordisk A/S. Expertise in drug development in cardiometabolic disease space.

Zach Gerhart-Hines
Associate Professor, PhD
CHIEF TECHNOLOGY OFFICER

15+ years experience in the obesity and diabetes fields with a focus on adipose tissue biology and cardiometabolic homeostasis.

Jakob Bondo Hansen
PhD
VICE PRESIDENT OF RESEARCH

10+ years experience in the obesity and diabetes fields with a focus on endocrine and adipose tissue physiology and pharmacology.

Thue Schwartz, Professor
MD, PhD
SCIENTIFIC GODFATHER

30+ years experience in G protein-coupled receptor pharmacology with a focus on receptor-based innovation and commercialization.